"Very Rare...": AIIMS Chief On AstraZeneca Vaccine-Linked Clotting

Dr Guleria said cases of vaccine-related clotting were uncommon - he estimated the odds at "1 in a million or less" - and that no events had been reported in India so far

The chances of adult recipients of the AstraZeneca coronavirus vaccine - made in India as Covishield - developing blood clots, even mild ones, is "very rare", AIIMS chief Dr Randeep Guleria told NDTV on Sunday. Dr Guleria also said that such cases were uncommon - he estimated the odds at around "1 in a million or less" - and that no events had been reported in the country so far. "This is a very rare side effect that was first thought to be a coincidence... now studies suggest a link to the vaccine. It is still very rare and not seen, so far, in India, although there are suggestions that one or two cases are here also," Dr Guleria said. What is it?